| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/23/2006 | US7049108 Processes for producing lactic acid using yeast transformed with a gene encoding lactate dehydrogenase |
| 05/23/2006 | US7049104 Single Nucleotide Polymorphism (SNP) testing, using two kinds of primers which are complementary to a mutant target and a wild-type target, and different in length or migration speed in electrophoresis |
| 05/23/2006 | US7049103 Method of evaluating drug efficacy and toxicity |
| 05/23/2006 | US7049101 Enzymes having high temperature polymerase activity and methods of use thereof |
| 05/23/2006 | US7049100 Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 05/23/2006 | US7049099 Recombinant human mannan-binding proteins and producing method of the same |
| 05/23/2006 | US7049098 Detecting preferential polypeptide in sample; generate expression vector containing preferential protein, express vector, detect preferential polypeptide in sample |
| 05/23/2006 | US7049097 Antibiotics-independent vector for constant high-expression and method for gene expression using the same |
| 05/23/2006 | US7049096 Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1 |
| 05/23/2006 | US7049095 DNA encoding IL-1 receptor accessory protein |
| 05/23/2006 | US7049094 Detection of modulator of transport protein activity; obtain sample containing transport protein, incubate with potential modulator, monitor binding activity, reduction in binding indicates effective modulator |
| 05/23/2006 | US7049092 drug screening for male antifertility agents by screening for inhibitors of said lipase which would have spermatogenesis inhibiting activity |
| 05/23/2006 | US7049089 Respiratory system disorders; cardiovascular disorders; controlling signal transduction |
| 05/23/2006 | US7049083 Methods for identifying modulators of N-type ion channel inactivation |
| 05/23/2006 | US7049079 Coupling factor 6 inhibitor and potentiator and use thereof |
| 05/23/2006 | US7049076 Method for assaying protein—protein interaction |
| 05/23/2006 | US7049075 Deoxyribonuclease IIβ proteins and cDNAs |
| 05/23/2006 | US7049071 Nucletide sequences coding protein for use as diagnostic tool in the detection of genetic damage |
| 05/23/2006 | US7049070 Detecting variation in nucleotide sequence pattern; obtain nucleotide squences, depolymerize, separate sequences, monitor mobility pattern of nucleotide sequences |
| 05/23/2006 | US7049067 Human immunodeficiency virus (HIV); which can bind to a specific site of the RNA; amplification; change in fluorescence upon hybridization |
| 05/23/2006 | US7049066 Diagnosis and treatment of myocardial failure |
| 05/23/2006 | US7049065 Method of preparing normalized and/or subtracted cDNA |
| 05/23/2006 | US7049064 Generating preferential microoarrays; obtain solid support, incubate with chemical intermediates, recover microarray |
| 05/23/2006 | US7049062 Assay for methylation in the GST-Pi gene |
| 05/23/2006 | US7049060 Secreted by hybridoma cell lines; hepatitis C virus (HCV) |
| 05/23/2006 | US7049059 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 05/23/2006 | US7048949 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 05/23/2006 | US7048930 Expression of core-glycosylated HCV envelope proteins in yeast |
| 05/23/2006 | US7048924 Combination antiviral and interleukin-2 therapy for HIV infection |
| 05/23/2006 | US7048923 Antibodies to mitogenic oxygenases |
| 05/23/2006 | US7048921 Neural transplantation using pluripotent neuroepithelial cells |
| 05/23/2006 | US7048920 A replication-competent adenovirus vector comprising an adenovirus gene essential for replication; use as antitumor agent |
| 05/23/2006 | US7048901 production method of the electrical connection structure, and electric wiring; carbon nanotube as the electrode and contacting the electrode with the biopolymer (DNA, RNA, or a protein) then applying an electric current between the electrode and biopolymer |
| 05/23/2006 | US7048211 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 05/23/2006 | CA2547572A1 Cattle beta-casein gene targeting vector using homologous recombination |
| 05/23/2006 | CA2335305C A bioluminescence resonance energy transfer (bret) system and its use |
| 05/23/2006 | CA2259550C Cosmetic or dermatological compound containing at least one natural, recombinant or analogous arachnid silk protein |
| 05/23/2006 | CA2075206C Production of recombinant polypeptides by bovine species and transgenic methods |
| 05/18/2006 | WO2006053315A2 Methods and compositions for treating cellular proliferative diseases |
| 05/18/2006 | WO2006053313A2 Elaiophylin biosynthetic gene cluster |
| 05/18/2006 | WO2006053246A2 A new sos 1 gene from halophila that confers salt tolerance |
| 05/18/2006 | WO2006053245A2 Retroviral vectors with introns |
| 05/18/2006 | WO2006053169A2 Pm29 and lea3 promoters and use in expression of transgenic genes in plants |
| 05/18/2006 | WO2006053155A2 Gp202: methods and compositions for treating cancer |
| 05/18/2006 | WO2006053147A1 Method of evaluating plant protection |
| 05/18/2006 | WO2006053131A1 Ladder assembly and system for generating diversity |
| 05/18/2006 | WO2006053125A2 Gp201: methods and compositions for treating cancer |
| 05/18/2006 | WO2006053021A2 Methods for engineering polypeptide variants via somatic hypermutation and polypeptides made thereby |
| 05/18/2006 | WO2006052914A2 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052912A2 Acyltransferase regulation to increase the percent of polyunsaturated fatty acids in total lipids and oils of oleaginous organisms |
| 05/18/2006 | WO2006052871A2 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | WO2006052870A2 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | WO2006052836A2 A system and method for establishing a local page and grid numbering system in a georgraphic referencing system |
| 05/18/2006 | WO2006052824A2 A mortierella alpina glycerol-3-phosphate o-acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052814A2 A mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052807A2 A dna molecule of mortierella alpina lpaat homolog |
| 05/18/2006 | WO2006052754A2 Ammonium transporter promoter for gene expression in oleaginous yeast |
| 05/18/2006 | WO2006052680A1 Compositions and methods for purifying nucleic acids from stabilization reagents |
| 05/18/2006 | WO2006052646A2 Derivation of embryonic stem cells |
| 05/18/2006 | WO2006052554A2 Eucalyptus urophylla transformation and selection |
| 05/18/2006 | WO2006052493A1 Polypeptides that bind baff and/or april |
| 05/18/2006 | WO2006052419A2 Nucleic acid enzyme light-up sensor utilizing invasive dna |
| 05/18/2006 | WO2006052391A2 Heterocyclic inhibitors of ires-mediated translation and methods of use thereof |
| 05/18/2006 | WO2006052363A2 Co-expression of multiple protein chains or subunits |
| 05/18/2006 | WO2006052224A1 Toxin-antitoxin system and applications thereof |
| 05/18/2006 | WO2006052016A1 METHOD OF SYNTHESIZING PROTEIN, mRNA IMMOBILIZED ON SOLID PHASE AND APPARATUS FOR SYNTHESIZING PROTEIN |
| 05/18/2006 | WO2006051997A1 Cystein dioxygenase inducer |
| 05/18/2006 | WO2006051991A1 Method of amplifying and detecting nucleic acid |
| 05/18/2006 | WO2006051990A1 Diagnostic method using nucleic acid amplification |
| 05/18/2006 | WO2006051988A1 Method of nucleic acid amplification |
| 05/18/2006 | WO2006051946A1 Novel polypeptide having protease inhibitory activity |
| 05/18/2006 | WO2006051944A1 Fluorescent protein |
| 05/18/2006 | WO2006051908A1 Cell-free protein synthesizing process |
| 05/18/2006 | WO2006051901A1 Cell-free protein synthesizing process |
| 05/18/2006 | WO2006051886A1 Method of presuming the risk of worsening in autoimmune disease accompanied by dysfunction due to tissue destruction |
| 05/18/2006 | WO2006051805A1 MUTANT INTERFERON α PROTEINS AND USE THEREOF |
| 05/18/2006 | WO2006051729A1 Method of isolating p450 gene |
| 05/18/2006 | WO2006051670A1 Gene expression level standardization method, program, and system |
| 05/18/2006 | WO2006051660A1 Method of producing l-amino acid |
| 05/18/2006 | WO2006051545A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | WO2006051418A2 Transcription factor of the zn binuclear cluster family of fungal regulators |
| 05/18/2006 | WO2006051396A1 Mutant porcine reproductive and respiratory syndrome virus |
| 05/18/2006 | WO2006051333A2 Leucine-rich repeat (lrr) motif containing proteins |
| 05/18/2006 | WO2006051172A1 Method for testing a compound for a therapeutic effect and a diagnostic method |
| 05/18/2006 | WO2006051127A1 Control of gene expression with the use of a transcription attenuator |
| 05/18/2006 | WO2006050949A2 Superagonistic anti-cd28 antibody |
| 05/18/2006 | WO2006050737A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 05/18/2006 | WO2006050734A2 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | WO2006050732A2 Lna oligonucleotides and the treatment of cancer |
| 05/18/2006 | WO2006050611A1 Antimicrobial peptides |
| 05/18/2006 | WO2006050584A1 Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi |
| 05/18/2006 | WO2006050571A1 Chlamydia antigens and uses thereof |
| 05/18/2006 | WO2006036406A3 Live microbial microbicides |
| 05/18/2006 | WO2006035221A3 Modification of plant development and morphology |
| 05/18/2006 | WO2006032436A3 Use of microproteins as tryptase inhibitors |
| 05/18/2006 | WO2006024867A3 Method for improved transgene expression |
| 05/18/2006 | WO2006020821A3 Compositions and methods using rna interference for control of nematodes |
| 05/18/2006 | WO2006019954A3 In vivo assays for modulation of smad-mediated signaling |
| 05/18/2006 | WO2006016275A3 Gastrin-specific interfering rna |
| 05/18/2006 | WO2006012414A3 Novel polyadenylation signal for use in expression vectors |